FINAL DIAGNOSIS:
PART 1: LYMPII MODES, RIGHT PELVIC. echsIOII —
ELEVEN LYMPH MODES. NEGATIVE FOR METASTATIC TUMOR (0/11).

PART 2: LYMPH MODES. RIGHT PERIAORTIC. EXCISION~
TWO LYMPH MODES. NEGATIVE FOR METASTATIC TUMOR (0(2).

PART 3: LYMPH MODE. LEFT PELVIO, EXOISION—

IIIII IIII IIII I III I IIIIIIIIIIIIIIIII
III IIIII I IIIIIIIIIIIII I II II II I I II IIIIIIIIIIII'II IIIIIIIIIII III III
ONE LYMPH MODE, NEGATIVE FOR MET ASTATIC TUMOR (OM).
PART 4: UTERUS WITH BILATERAL AD

N TOTAL LAPA
SALPINGO-OOPHORECTOMY _ EXA. ROSCOHC HYSTERECTOMY AND BILATI I III.

ADEIOOARCINOMA OF ENDOMETRIUM.
F IGO G RADE III.

THE TUMOR INVADEO 12% OF THE MYOM TH ‘
MYOM UM). ETRIAL IOKNESS (0.3 OM INVASION OF 2.5 | . THICK

me TUMOR INVOLVES APPROXIMATELY ms OF THE snowman cm,"
THE TUMOR rocALLv INVOLVES THE CERVICAL STROMA. SURFACI ‘

”MVASCULAR SPACE INVASION IS IDEN‘HFIED (WITHIN THE CERVICAL STROMAI ‘ EISSELS, SLIDE
M 8HOW8 WPLEX ATYPICAL HYPERPLASIA.

uum:o453cne5-
B

"‘ IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIed
I

339C-4ABQ-A236-CEAE733ADSF6

I“? 9!”?

THE BACKGROUND ENDOMETRIU
ALL ADNEXAE ARE NEGATIVE FOR TUMOR.

3:97!

9

COMMENT!
Tho recent ondomotﬁal c was I
a few glands m I dnnttﬁem Mahmud as modem-Iv dlthmnttm adonmrdnoma

. . Although
a In thIs tumor, mo than
a. FIGO 9 III. n 50% of tho tumor shows soIId 91'th pattnm,

and I . Indore grad“

{/0'V3/

1119 companlou pelvic wash cytology specimen In nogaﬂv. To, WWW , O ..
MICROSCOPIC: .
MIcroscopIc examlnaﬂon substantiates the above dIagnosIl.

Antibody/Antigen
CD31

D2-40

Mil/A33

Result:
Highlights endothelium and supports LVSI.

Highlights lymphatic endothelium and lupports lymphatic space it‘ aion.
Highlights tumor cells within vessels.

IIIEO WWM‘W‘;

Utilizing formalin-fixed (8-‘96 hour range) . paraffin embedded tisiuo. immenstolou Is
performed. with the following solacted antibodies and designated antibody cLoneIa) . I; acted
against the tollowing antigenic target“), with adequate positive and negative into” I. and
external controls. Antibodies are optimized appropriate for fixation times.

ANTIBODY CLONE TARGET ANTIGm

II IT’I'I/ﬂ/

g/Oféf $0“ 'IWWWM I

CD 31

132-40
ASL/A33
Microsystema
RB/ncs

CASE SYNOPSIS:

vao
92-40
R31/A33

endothel Sum
Lymphatic Endothel ium
cart: inm-

SYNOP'TIC - PRIMARY UTERINE ENDOMET'RlethRCINOMA E- CARCINOSARCOMA: HYSTEREC‘I'I I Y
SPECIM
‘ ' OS
TUMOR TYPE: Endomotrmd adenoearanoma. N .
IOI um) [combimd nrchthctural and nudeaﬂ‘
HISTOLOGIC GRADE (aplthel noopIP differentiated (FIGO 3)

ARCHITECTURAL GRADE: PoorIy dmemntiated
NUCLEAR GRADE: Grade 2 .
TUMOR SIZE: Maximum dImansIon'. 25 mm

CE INVOLVEMENT:
PERCENT OF ENDOMETRIM‘ SURFA Antartor endomyornctn‘um: 70 '56, Posterior endomyomatrlum: 70 °/.

DEPTH OF INVASION: Less than 1/2 thickness of myomartum

 
  
  
 
    
  
 
  

STRUGTURES 'WongION 33AM stoma
GIOLYNIPHATIC INV : .
cgE-NEOPLABTIC CONDITIONS: Complex endometnal hyperptaah: wIth atypia ‘
LYMPI-I MODES POSITIVE: Number Of lymph nodes postIVeu 0 . ‘ ’ “I". - 1
LYMPl-I NODES EXAMINED: Total number OI lymph node. axamlned. 1 :mmsmmmm
T STAGE. PATHOLDGIC: 9T2 W"
N STAGE. PATHOLOGIC: pNO mm ”mm: WV _._._ ‘
M STAGE. PATHOLOGIC: {tot appIIcabIo mimmfoymhim
FIGO STAGE:

 
 
 

 

. , I
ﬁleIIIcImey. "I ,l . . I
Reviewerlnilial [114” III: Renewed, 7 <
._~_._

 

   
  

PATIENT HISTORY: _
CHIEF COMPLAINT! PRE-OPI POST-0P DIAGNOSIS: Endametnal cancer.

ATE: Not vided . ‘ f _
EESEEDURE; TE; Iapamsoopic hysterectomy. bIIatemI salpsngo-oophmectomy. perIc and penaoItIc lymph I t a dissectIon.
c tosmpy,

SYSECIFIC CLINICAL QUESTION: Not prOvIdeO.
OUTSIDE TISSUE DIAGNOSISINOI prowded.
PRIOR MALIGNANCY: Not provIded. .
CHEMORADIATION THERAPY; Nat prOVIdod.
OTHER DISEASES: Not pvaded.

